 |
antagonist of the endosomal Toll-like receptors (TLRs) 7, 8, and 9 |
|---|---|
| Trade Name | |
| Orphan Indication | Waldenstrom macroglobulinemia |
| USA Market Approval | USA |
| USA Designation Date | 2014-12-23 00:00:00 |
| Sponsor | Idera Pharmaceuticals, Inc.;167 Sidney Street;Cambridge, Massachusetts, 02139 |
